Acadian Asset Management LLC / MYGN
Acadian Asset Management LLC’s Myriad Genetics Inc Position
Does Acadian Asset Management LLC own Myriad Genetics Inc (MYGN)? Yes — 2.31M shares worth $10M (+0.01% of its 13F portfolio) as of Q1 2026, up from 986.1K shares the prior filed quarter.
Position Value
$10M
Q1 2026
Shares
2.31M
% of Portfolio
+0.01%
Quarters Held
15
currently held
Position History MYGN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 2.31M | $10M | +0.01% |
| Q4 2025 | 986.1K | $6M | +0.01% |
| Q3 2025 | 810.5K | $6M | +0.01% |
| Q2 2025 | 969.1K | $5M | +0.01% |
| Q3 2021 | 2.7K | $85,000 | 0.00% |
| Q1 2021 | 47.8K | $1M | +0.01% |
| Q4 2020 | 305.8K | $6M | +0.02% |
| Q3 2020 | 305.8K | $4M | +0.02% |
| Q2 2020 | 514.1K | $6M | +0.03% |
| Q1 2020 | 580.9K | $8M | +0.05% |
| Q4 2019 | 793.2K | $22M | +0.10% |
| Q3 2019 | 824.6K | $24M | +0.10% |
| Q2 2019 | 1.30M | $36M | +0.17% |
| Q1 2019 | 1.51M | $50M | +0.22% |
| Q4 2018 | 1.86M | $54M | +0.27% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Acadian Asset Management LLC’s full portfolio or all institutional holders of MYGN.